The launch of The Natasha Clinical Trial is good news not just for the industry, but for the world at large. Fifteen-year-old Natasha Ednan-Laperouse tragically died in 2016 after eating an incorrectly labelled baguette containing sesame seeds – to which she was severely allergic. But a groundbreaking £2.2m study, funded by the Natasha Allergy Research Foundation, is on a quest to find a practical treatment. The goal? To show that everyday foods containing peanuts or milk can be used as alternatives to expensive pharmaceutical drugs to desensitise patients.
The trailblazing trial has the potential to transform the lives of those living with food allergies. It gives hope for a possible lifelong treatment for millions who have suffered, doing so for a fraction of the cost of previous studies. Head to page 5 to find out more.
Also in this issue, I talk to Neal Bates, MD of expanding pizza concept Rudy’s for this month’s lead interview (p.18); we explore the market for the nation’s favourite alcoholic drink in The Beer Report (p.24); and tuck into children’s menus, from planning to plating up (p.38).
If you haven’t already, head over to our socials and give them a follow to keep on top of all the UK’s restaurant action. But other than that, sit back, relax and enjoy!
Genna Ash-Brown
Editor